Navigation Links
Analysis of FDA Adverse Events Data Reveals at Least 106 Serious Conditions Reported Among Reglan Users
Date:5/8/2009

An analysis of the Food and Drug Administration’s Adverse Event Reporting System has identified at least 106 cases of tardive dyskinesia or other movement disorders reported among users of Reglan or its generic version, metoclopramide. Tardive dyskinesia is a neurological disorder characterized by involuntary, repetitive movements of the extremities, including lip smacking, grimacing, tongue protrusion, rapid eye movements or blinking, puckering and pursing of the lips, or impaired movement of the fingers. These symptoms are rarely reversible and there is no known treatment.

(Vocus) May 8, 2009 -- An analysis of the Food and Drug Administration’s Adverse Event Reporting System has identified at least 106 cases of tardive dyskinesia or other movement disorders reported among users of Reglan or its generic version, metoclopramide.

Reglan and metoclopramide were approved by the FDA only for short-term treatment of certain gastrointestinal conditions, such as gastroesophageal reflux disease or diabetic gastroparesis. However, the manufacturers of these drugs derive substantial profit from their long-term use. The drugs work by speeding up the movement of the stomach muscles, which helps to increase the rate at which food moves from the stomach to the intestines.

In February 2009, the FDA forced the manufacturers of Reglan and metoclopramide to add a “black-box” warning to their labels about the strong connection between tardive dyskinesia and the long-term u
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Webcast Alert: Release of Economic Analysis Revealing $734 Billion in Savings Produced by Using Generic Medicines in 1999 - 2008
2. New data analysis shows possible link between childhood obesity and allergies
3. STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase
4. Genetic analysis may predict risk of invasive bladder cancer
5. Sirion Therapeutics Announces Positive Results From Interim Analysis of Phase II Trial and Receives FDA Fast Track Designation for Fenretinide
6. How Can We Improve Our Elementary School System? - Unique Market Research Analysis of the Subconscious of Parents
7. China Medical Technologies Announces Receipt of SFDA Quality Testing Certificate for its SPR-based Analysis System
8. CDC analysis finds unique social and behavior intervention helps reduce MRSA rates up to 62 percent
9. Edifecs Announces New Version of Its Integrated HIPAA 5010 and ICD-10 Analysis and Migration Solution
10. An even-handed analysis of environmental policy
11. New Analysis: Light and Intermittent Smokers Overlooked in Traditional Tobacco Research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Analysis of FDA Adverse Events Data Reveals at Least 106 Serious Conditions Reported Among Reglan Users
(Date:4/1/2015)... (PRWEB) April 01, 2015 Taking an ... National League for Nursing Commission for Nursing Education ... has approved the first NLN CNEA Board of Commissioners. ... FAAN, ANEF, the 15-member board will provide leadership and ... overseeing all accreditation decisions for nursing programs that seek ...
(Date:4/1/2015)... VA (PRWEB) April 01, 2015 ... College of American Pathologists (CAP), the Association for ... Clinical Oncology (ASCO) today released a draft of ... molecular marker testing for patients with primary or ... establish standard molecular marker testing, guide targeted therapies, ...
(Date:4/1/2015)... Dr Roz Kamani, a Vancouver medical aesthetic doctor, ... patients an opportunity to learn more about the latest ... which is an exclusive VIP event conducted three times ... Clinic. It is attended by Dr Roz Kamani’s suppliers ... and services that are on offer. , In ...
(Date:4/1/2015)... 01, 2015 Tempaper has joined forces ... virtual giving campaign that will raise critical funds to ... muscle disease across the United States. , Throughout the ... Tempaperdesigns.com will automatically receive free domestic ground ... and urgently needed progress to children and adults affected ...
(Date:4/1/2015)... 2015 IQ Formulations , one of ... supplement companies in the U.S., today is commending GNC for ... control standards for its herbal supplements.* GNC vowed that its ... ensure the accuracy of labeling on its products. , ... IQ Formulations CEO Jay Cohen said: , “In ...
Breaking Medicine News(10 mins):Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 2Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 3Health News:ASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker Testing Guideline and Announce Opening of Public Comment Period 4Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2
... common cause of death and disability in children and adolescents, ... a new study by UCLA researchers, the effects of a ... can linger for years. , Reporting in the May ... author and a UCLA post-doctoral fellow, and senior author Robert ...
... Ky., May 13 We,ve all made mistakes: bell bottoms, scrunchies ... in the past. Thanks to advances in skin care and ... In fact, it,s downright dangerous. According to the National Cancer ... in 2009 resulting in about 1,000 deaths. Skin cancer is ...
... was recently recognized by the Art Directors Club ... Awards Exhibition.ScienceFirst graphic designer Michelle Feingold won a ... a speaker training creative platform for a top-tier, ... received Certificates of Excellence. One of the entries ...
... combination medication approved with the extended-release form of ... Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, ... announced that the U.S. Food and Drug Administration ... medication ACTO plus met(R) (pioglitazone HCl and ...
... ,Covering All the Bases® Hitting Challenge, during Major League Baseball,s ,4ALS ... famous ,Luckiest Man, farewell speech as he battled the disease that ... ... (Vocus) May 13, 2009 -- The ALS Association,s is launching the ...
... technology leader in email and file archiving ... and storage management, today announces the release ... Suite with SharePoint Archiving at Microsoft TechEd ... Email & File Archive Enterprise Suite with ...
Cached Medicine News:Health News:UCLA study shows traumatic brain injury haunts children for years 2Health News:Get Sun Smart at the Spa 2Health News:FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes 2Health News:FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes 3Health News:FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes 4Health News:70th Anniversary of Lou Gehrig's Farewell Speech: The ALS Association Launches the 'Covering All the Bases Hitting Challenge' 2Health News:70th Anniversary of Lou Gehrig's Farewell Speech: The ALS Association Launches the 'Covering All the Bases Hitting Challenge' 3Health News:MessageSolution Releases Email & File Archive Enterprise Suite with SharePoint Archiving at Microsoft TechEd North America 2009 2Health News:MessageSolution Releases Email & File Archive Enterprise Suite with SharePoint Archiving at Microsoft TechEd North America 2009 3Health News:MessageSolution Releases Email & File Archive Enterprise Suite with SharePoint Archiving at Microsoft TechEd North America 2009 4Health News:MessageSolution Releases Email & File Archive Enterprise Suite with SharePoint Archiving at Microsoft TechEd North America 2009 5
(Date:4/1/2015)... -- Salix Pharmaceuticals, Ltd. (the " Company " or " ... International, Inc. (NYSE: VRX ) (TSX:VRX), today announced ... Make-Whole Fundamental Changes and Merger Event, Fundamental Change Company ... to Purchase (the " Notice ") to holders of ... Notes "), pursuant to the Indenture, dated as of ...
(Date:4/1/2015)... Trinity Biotech plc (Nasdaq: TRIB ... products for the point-of-care and clinical laboratory markets, ... wholly-owned subsidiary (the "Issuer"), intends to offer, subject ... principal amount of Exchangeable Senior Notes due 2045 ... pursuant to Rule 144A under the Securities Act ...
(Date:4/1/2015)... , April 1, 2015  Pittman Motors ... introduction of PLG24, PLG42K, PLG42S, PLG52, and PLG63 ... Pittman brush and brushless DC motors and complement ... new products add 35 standard motor-gearbox family combinations ... planetary gearboxes deliver high torque loads with excellent ...
Breaking Medicine Technology:Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 2.75% Convertible Senior Notes Due 2015 7Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 2Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 3Trinity Biotech plc Announces Proposed Offering of $100 Million of Exchangeable Senior Notes due 2045 4Pittman Motors Expands PLG Planetary Gearbox Offering 2
... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Health Care Conference on Wednesday, March 9, 2011 at 11:00 ... Interested parties may access a live webcast of the presentation ... It is recommended that listeners log on 15 ...
... A new ad campaign warns Mississippi legislators that ... prescription drug benefits and undermine the ability of pharmacy ... Mississippi families and businesses, said the Pharmaceutical Care Management ... put the State Board of Pharmacy (instead of the ...
Cached Medicine Technology:Onyx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference 2New Ad Campaign: Secret Provision Raises Taxes on Prescription Drug Benefits, Creates 'Conflict of Interest' 2
Headlight module is mounted on UltraLite Plus sweatband....
... rapid rise in intracranial ... intervention and continuous monitoring. ... technology that gets to ... Its versatility makes it ...
... The CODMAN ICP Monitoring ... measurements of intracranial pressure ... or intraventricular levels. The ... rather than through a ...
... The Polaris system delivers the ... cost effective and easy to use, ... level of precision measurement with unprecedented ... both active and passive tools, the ...
Medicine Products: